Bionano Genomics (BNGO) Asset Utilization Ratio (2018 - 2026)
Bionano Genomics (BNGO) posted Asset Utilization Ratio of 0.42 for Q1 2026, up 11.19% sequentially from 0.37 in Q4 2025, and up 13.14% YoY from 0.37 in Q1 2025.
Bionano Genomics (BNGO) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Bionano Genomics has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.42 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 13.14% year-over-year to 0.42 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.42 (up 13.14% YoY) and the FY2025 annual result came in at 0.38, up 79.45% from the prior year.
- Asset Utilization Ratio rose to 0.42 in Q1 2026 per BNGO's latest filing, from 0.37 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.42 in Q1 2026 and troughed at 0.06 in Q1 2022.
- A 5-year average of 0.23 and a median of 0.2 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio soared 127.63% in 2024, then dropped 0.46% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.09 in 2022, then soared by 106.9% to 0.18 in 2023, then surged by 105.88% to 0.38 in 2024, then decreased by 0.46% to 0.37 in 2025, then gained by 11.19% to 0.42 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.42, 0.37, and 0.37 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 0.54 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 0.46 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.34 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 0.64 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 0.73 |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 0.81 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 0.59 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 0.34 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 0.56 |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | 0.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.54 |
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.37 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.36 |
| Mar 31, 2025 | 0.37 |
| Dec 31, 2024 | 0.38 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.20 |
| Dec 31, 2023 | 0.18 |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.11 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.08 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.04 |